Quest Pharmaceuticals is dedicated to helping sponsors meet the challenges posed by the dynamic environment of pharmaceutical Research and Development globalization. Since its inception in 1995, Quest Pharmaceutical Services has been providing high quality Drug Metabolism and Pharmacokinetics (DMPK) contract services to pharmaceutical and biotechnology clients worldwide. In January 2004, Quest Pharmaceuticals established a global presence with the opening of the state-of-the-art bioanalytical facility in Taipei, Taiwan. QPS-Taiwan offers strategic solutions for both Asian-Pacific Rim and US based companies with sites or trials overseas. QPS-Taiwan also provides cost saving options for companies operating in the US.

Harmonization between QPS facilities was successfully accomplished by mobilizing key members of the QPS scientific staff to form and train the QPS-Taiwan team of highly skilled professionals. Systems, processes, and the Standard Operating Procedures fine-tuned in the US were transferred and implemented in our Taiwan facility, thereby establishing an operation with the same high degree of quality and compliance characteristic of QPS in the United States. Although integrated, QPS-US and QPS-Taiwan each retain their local identities and local responsiveness. Therefore, sponsors benefit by consistently receiving excellence in quality and service from the Quest Pharmaceuticals Services location that best fits their global needs.

QPS operates 37 mass spectrometers worldwide. LC/MS/MS assays are validated in compliance with the latest FDA Guidance on Bioanalytical Method Validation Criteria.

Come and discover QPS for the Quality You Expect, Service You Trust, and Turnaround You Need.